ROCKWELL MEDICAL, INC. Repayments of Debt
ROCKWELL MEDICAL, INC. (RMTI) reported Repayments of Debt of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2025-03-20
- ROCKWELL MEDICAL, INC. repayments of debt for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- ROCKWELL MEDICAL, INC. repayments of debt for the quarter ending 2023-12-31 was $1.50M, a 70.00% decline year-over-year.
- ROCKWELL MEDICAL, INC. repayments of debt for the quarter ending 2023-09-30 was $500.00K, a 66.67% decline year-over-year.
- ROCKWELL MEDICAL, INC. repayments of debt for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- ROCKWELL MEDICAL, INC. repayments of debt for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- ROCKWELL MEDICAL, INC. repayments of debt for fiscal 2023 was $2.00M, a 82.98% decline from fiscal 2022.
- ROCKWELL MEDICAL, INC. repayments of debt for fiscal 2022 was $11.75M, a 1466.67% increase from fiscal 2021.
- ROCKWELL MEDICAL, INC. repayments of debt for fiscal 2021 was $750.00K.
| Period end | Repayments of Debt 3 month | Repayments of Debt 6 month | Repayments of Debt 9 month | Repayments of Debt 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $0.00 10-K · filed 2025-03-20 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | |||
| 2023-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $2.00M derived: sum of 2 quarters · filed 2025-03-20 | $2.00M derived: sum of 3 quarters · filed 2025-03-20 | $2.00M 10-K · filed 2025-03-20 |
| 2023-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $500.00K derived: sum of 2 quarters · filed 2024-11-12 | $500.00K 10-Q · filed 2024-11-12 | $5.50M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | $5.00M derived: sum of 3 quarters · filed 2024-03-21 | $6.50M derived: sum of 4 quarters · filed 2024-03-21 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | $5.00M derived: sum of 2 quarters · filed 2024-03-21 | $6.50M derived: sum of 3 quarters · filed 2024-03-21 | $9.50M derived: sum of 4 quarters · filed 2024-03-21 |
| 2022-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $6.50M derived: sum of 2 quarters · filed 2024-03-21 | $9.50M derived: sum of 3 quarters · filed 2024-03-21 | $11.75M 10-K · filed 2024-03-21 |
| 2022-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $4.50M derived: sum of 2 quarters · filed 2023-11-14 | $6.75M 10-Q · filed 2023-11-14 | $7.50M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $5.25M 10-Q · filed 2023-08-14 | $6.00M derived: sum of 3 quarters · filed 2023-08-14 | $6.00M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $2.25M 10-Q · filed 2023-05-15 | $3.00M derived: sum of 2 quarters · filed 2023-05-15 | $3.00M derived: sum of 3 quarters · filed 2023-05-15 | $3.00M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $750.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $750.00K derived: sum of 2 quarters · filed 2023-03-30 | $750.00K derived: sum of 3 quarters · filed 2023-03-30 | $750.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-04-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |